Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial.
Martin BalikMichal MalyTomas BrozekJan RulisekMichal PorizkaRobert SachlMichal OtahalPetr BrestovanskyEva SvobodovaMarek FlaksaZdenek StachJan HorejsekLukas VolnyIvana JurisinovaAdam NovotnyPavel TrachtaJan KunstyrPetr KopeckyTomas TencerJaroslav PazoutJan BelohlavekFrantisek DuskaAdela KrajcovaPetr WaldaufPublished in: Intensive care medicine (2023)
Propafenone does not provide better rhythm control at 24 h yet offers faster cardioversion with fewer arrhythmia recurrences than with amiodarone, especially in patients with a non-dilated left atrium. No differences between propafenone and amiodarone on the prespecified short- and long-term outcomes were observed.